 CytoSorbents NASDAQ: CTSO releases its next round of earnings this Tuesday, August 04. Heres Benzingas essential guide to CytoSorbentss Q2 earnings report.Earnings and Revenue CytoSorbentss EPS is expected to be at -0.08 on sales of 9.66 million, according to Wall Street analysts.In the same quarter last year, CytoSorbents posted a loss of -0.110 per share on sales of 6.23 million. If the company were to post earnings in-line with the consensus estimate when it reports Tuesday, EPS would be down 27.27. Sales would be up 38.0 from the year-ago period. Heres how the companys reported EPS has compared to analyst estimates in the past:Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019 EPS Estimate -0.13 -0.17 -0.22 -0.14 EPS Actual -0.10 -0.12 -0.21 -0.11 Revenue Estimate 7.00 M 6.80 M 6.66 M 6.17 M Revenue Actual 8.71 M 7.43 M 6.09 M 6.23 M Stock Performance Over the last 52-week period, shares are up 45.87. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.View more earnings on CTSODont be surprised to see the stock move on comments made during its conference call. CytoSorbents is scheduled to hold the call at 16:45:00 ET and can be accessed here: more from Benzinga 17 Healthcare Stocks Moving In Mondays Pre-Market SessionC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 